藥品臨床綜合評(píng)價(jià)主題選指南
《藥品臨床綜合評(píng)價(jià)主題選指南》項(xiàng)目組
中圖分類號(hào)R95 文獻(xiàn)標(biāo)志碼A 文章編號(hào) 1001-0408(2025)08-0897-06
DOI 10.6039/j.issn.1001-0408.2025.08.01
Guidelines for topic selection for comprehensive clinical evaluation of drugs Project Team of Guidelines for Topic Selection for Comprehensive Clinical Evaluation of Drugs
ABSTRACTOBJECTIVETo promote thestandardizedandhigh-qualitydevelopmentofcomprehensiveclinicaldrug evaluation, and enhace thequalityofcomprehensiveevaluationevidenceanditsapplicationtransformationvalueMETHODSThe guidelines werforulatedinaccrdancewiththelatestdefinitionofguidelinesprovidedbytheInsttuteofMedicineoftheNationalAcademy ofSciencesandbasedonthemethodologyestablishedbytheWorldHealthOrganizationstandardguidelinesAnindexsystemfor topicselectionwasconstructedusingtheDelphimethod,andweightsforeachindexwereasignedthroughtheanalytic hierarchy process.Researchevidencewasestablishedfollwing the principlesofevidence-basedmedicineTheevidencegrading evaluation wasconductedusing theevidence grading systemof the ChinaEvidence-BasedMedicine Center,andrecommendationopinions wereformed viaexpertconsensus.RESULTSGuidelines forTopic Selection forComprehensive ClinicalEvaluationof Drugs (hereinafterreferredtoas“theuidelines")were sucessullydeveloped,encompassingtheorganizationandmanagementoftoic selectioneviewprocesesandealuatinmethodsTheevaluatinindexsstemforopicelectionwasestablished,mprising primary indexes,9secondary indexes,and17tertiary indexes.CONCLUSIONSThedevelopment of the Guidelines providesa standardizedtopicelectionolfortheproposedresearchworkofclinicalcomprehensiveevaluationofdrugsenhancesthequality of evaluations, facilitates result transformation, and supports scientific health decision-making.
KEYWORDSclinical comprehensive evaluation of drugs;topic selection; guideline; evaluation index system
藥品臨床綜合評(píng)價(jià)是藥品供應(yīng)保障決策的重要技術(shù)工具。(剩余11708字)
- 藥品臨床綜合評(píng)價(jià)主題選指南...
- 我國(guó)公立中醫(yī)類醫(yī)院中藥師(士)...
- 患者參與藥物監(jiān)管的國(guó)際經(jīng)驗(yàn)與啟...
- 基于多準(zhǔn)則決策分析的縣域醫(yī)共體...
- 烏司他丁改善順鉑致心肌損傷的作...
- 類葉牡丹關(guān)節(jié)注射液治療類風(fēng)濕性...
- 異鼠李素通過(guò)上調(diào)SLC25A2...
- 布美他尼對(duì)慢性阻塞性肺疾病模型...
- 伊魯阿克治療ALK陽(yáng)性晚期NS...
- 羅哌卡因聯(lián)合羥考酮用于髖關(guān)節(jié)置...
- 替爾泊肽不良事件信號(hào)挖掘與分析...
- 腸內(nèi)免疫微生態(tài)營(yíng)養(yǎng)聯(lián)合 ω-3...
- 雌二醇片/雌二醇地屈孕酮片聯(lián)合...
- 環(huán)泊酚復(fù)合局麻用于老年患者痔瘡...
- 過(guò)敏性紫癜性腎炎患兒他克莫司血...
- 1例熱紫鏈霉菌肺炎診治過(guò)程及文...
- 克拉霉素潛在不良藥物相互作用分...
- 藥物防治糖皮質(zhì)激素性骨質(zhì)疏松的...
- 抗VEGF藥物治療糖尿病性黃斑...
- 鈣離子通道調(diào)節(jié)劑治療糖尿病周圍...
- 中藥調(diào)控NLRP3炎癥小體改善...
- 生理藥代動(dòng)力學(xué)模型在EGFR-...
- 中藥調(diào)控PI3K/Akt信號(hào)通...